Drug Trial Radar · NCT00784225
S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
Last checked: Nov 20, 2026Latest source record: Aug 14, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13,475
Actual
Start
Jul 2004
Primary completion
Nov 2017
Study completion May 2018
Sponsor
- Lead sponsor
- SWOG Cancer Research NetworkResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI); National Eye Institute (NEI)
- First posted
- Nov 3, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- Male only, from 50 years, up to 120 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
RATIONALE: Aging may affect a person's vision. Vitamin E and/or selenium may help prevent cataracts or age-related macular degeneration in men receiving these drugs as part of a clinical trial for the prevention of prostate cancer. PURPOSE: This clinical trial is studying vitamin E and/or selenium to see how well they work in preventing cataract and age-related macular degeneration in men enrolled on SELECT (SWOG-S0000).
Conditions
- Cataract
- Macular Degeneration
Interventions
seleniumDrug
200 mcg daily for 7-12 years
vitamin EDrug
400 IU daily by mouth for 7-12 years
vitamin E placeboDrug
daily for 7-12 years
selenium placeboDrug
daily for 7-12 years
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Visually Significant Age-related Macular Degeneration (AMD)Time frame: Every 6 months, up to 7 years
- Number of Participants With Cataract and Best Corrected Visual-acuity of 20/30Time frame: Every 6 months, up to 7 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Harvard Medical School
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.